Vnitr Lek 2006, 52(1):51-56

Vascular complications after direct percutaneous coronary interventions

M. Orban1,*, O. Hlinomaz1, F. Lehár1, M. Rezek1, M. Eisenberger1, Z. Konečný2, L. Groch1
1 I. interní kardioangiologická klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta prof. MUDr. Jiří Vítovec, CSc., FESC
2 II. chirurgická klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Jindřich Leypold, CSc.

Objectives:
We assessed the rate and identified risk factors for postprocedure vascular complications following direct percutaneous intervention (dPCI).

Methods:
Data were collected on 881 consecutive patients who underwent dPCI in our cath-lab from January 2002 to December 2003. Multivariate regression was used to identify characteristics associated with vascular complications.

Results:
Out of 881 patients, hematoma was found in 148 (16.8 %) cases. Pseudoaneurysm was detected by ultrasound in 40 (4.5 %) patients, 5 (0.6 %) patients underwent surgery. Variables associated with increased risk included age, female sex, low body mass index (BMI) and body surface area (BSA) and presence of diabetes mellitus.

Conclusions:
Predicting the risk of post-PCI vascular complications is feasible. This information may be useful for clinical decision-making and institutional efforts at quality improvement.

Keywords: pseudoaneurysm; direct percutaneous coronary intervention; myocardial infarction

Received: April 4, 2005; Accepted: November 8, 2005; Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Orban M, Hlinomaz O, Lehár F, Rezek M, Eisenberger M, Konečný Z, Groch L. Vascular complications after direct percutaneous coronary interventions. Vnitr Lek. 2006;52(1):51-56.
Download citation

References

  1. Winthrop D, Piper, David J et al. Predicting vascular complications in percutaneous coronary interventions. American Heart J 2003; 145: 1022-1029. Go to original source... Go to PubMed...
  2. Ricci MA, Trevisani GT, Pilcher DB. Vascular complications of cardiac catheterization. Am J Surg 1994; 167: 375-378. Go to original source... Go to PubMed...
  3. Popma JJ, Satler LF, Pichard AD et al. Vascular complications after balloon and new device angioplasty. Circulation 1993; 88: 1569-1578. Go to original source... Go to PubMed...
  4. Muller DW, Shamir KJ, Ellis SG et al. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992; 69: 63-68. Go to original source... Go to PubMed...
  5. Waksman R, King SB III, Douglas JS et al. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995; 75: 886-889. Go to original source... Go to PubMed...
  6. Blankenship JC, Hellkamp AS, Aguirre FV et al. Vascular access site complications after percutaneous coronary intervention with abciximab in the evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial. Am J Cardiol 1998; 81: 36-40. Go to original source... Go to PubMed...
  7. Topol EJ. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. Circulation 1998; 97: 211-218. Go to original source... Go to PubMed...
  8. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997; 336: 1689-1696.
  9. The RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty: Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation 1997; 96: 1445-1453. Go to original source... Go to PubMed...
  10. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes: platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy. N Engl J Med 1998; 339: 436-443. Go to original source... Go to PubMed...
  11. Ellis K, Boccalandro F, Burjonroppa S et al. Risk of Bleeding Complications Is Not Increased in Patients Undergoing Rescue versus Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. J Interv Cardiol 2005;18: 361-365. Go to original source... Go to PubMed...
  12. Jaspers L, Benit E Immediate sheath removal after PCI using a Femostop is feasible and safe. Results of a registry. Acta Cardiol 2003; 58: 535-537. Go to original source... Go to PubMed...
  13. Rinder MR, Tamirisa PK, Taniuchi M et al. Safety and efficacy of suture-mediated closure after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001; 54: 146-151. Go to original source... Go to PubMed...
  14. Nikolsky E, Mehran R, Halkin A et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis.J Am Coll Cardiol 2004; 44: 1200-1209. Go to original source... Go to PubMed...
  15. Tuna M, Raupach J, Chovanec V et al. Postkatetrizační pseudoaneurysmata. Interv Akut Kardiol 2004; 3: 128-130.
  16. Morgan R, Belli AM. Current treatment methods for postcatheterization pseudoaneurysms. J Vasc Interv Radiol 2003; 14: 697-710. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.